News | March 11, 2015

Digitizing Heart Cell Crosstalk May Help Locate Epicenters of Dangerous Heart Rhythms

Pinpointing the origin of arrhythmias could lead to new, more precise therapies

arrhythmia, heart cells, mapping, crosstalk, Johns Hopkins, Ashikaga

March 11, 2015 — A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.

The work, the scientists say, could form a blueprint for vastly more precise imaging tests that capture cell-to-cell communication and pinpoint the tiny clusters of cells at the epicenter of complex, life-threatening arrhythmias. Such imaging approaches, they add, would enable precision-targeted, minimally invasive treatments that eliminate rhythm-disrupting hotspots in the heart’s electrical system.

The approach, described online March 4 in the Journal of the Royal Society Interface, is inspired by so-called information theory and built on the premise that cell-to-cell interaction follows a classic model of communication consisting of source, transmitter and receiver. Translating those cellular “conversations” into digital form — a series of zeroes and ones that can be easily read and imaged by a computer — can help spot breakdowns in communication that form the epicenters of dangerous rhythm disturbances.

“Successful arrhythmia treatment depends on correctly identifying the epicenter of the malfunction,” Ashikaga says. “We cannot begin to develop such precision-targeted therapies without understanding the exact nature of the malfunction and its precise location. This new model is a first step toward doing so.”

At the heart of the new model is the idea that heart muscle cells act as analog-to-digital converters, taking up information from their surroundings, converting or interpreting the information, and transmitting the message to neighboring cells. Ashikaga and colleagues say that capturing and quantifying information transmitted from cell to cell can help “catch” aberrant signals — or communication breakdowns — as they trigger electrical firestorms that cause the heart to beat abnormally and compromise its ability to pump blood.

The location of such communication glitches has been notoriously challenging to pinpoint with standard electrocardiograms, or EKGs, which provide limited information and are most helpful in diagnosing the type of arrhythmia rather than the exact cellular origin of the rhythm disturbance.

In their new model, the researchers mapped cellular information flow by creating computer representations of normal and abnormal heartbeats, ranging from simpler benign arrhythmias with well-defined epicenters to dangerous rhythms that arise in multiple hotspots. The scientists then “digitized” the electric flow by converting the electrical signals transmitted by cells into bits — the zeroes and ones that are the basic units of information in computing and digital communications.

Next, they measured how much information was generated, transmitted and received during normal and abnormal heart rhythms and plotted the information onto a 2-D map to create an image of the arrhythmia.

The different types of arrhythmias generated markedly distinct spatial profiles. By contrast, regular EKG tracings of the same rhythm disturbances looked similar with a lot of overlapping features, an observation suggesting that quantifying and digitizing information flow inside the heart would far more reliably distinguish one form of arrhythmia from another.

Current therapies for dangerous rhythms, including medication, catheter ablation or implanted defibrillators that shock the heart back into normal rhythm, are not always effective or have serious downsides. But pinpointing the origin of dangerous arrhythmias could lead to new therapies and improve the precision of surgical ablation, a minimally invasive procedure that uses heat energy to burn the hotspots that trigger aberrant rhythms. Ablation works well for simple rhythm disorders with a well-defined hotspot, but is far less effective for complex arrhythmias originating from multiple hotspots that cannot be precisely located with standard imaging techniques.

For more information: www.hopkinsmedicine.org

Related Content

The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Cardiologs ECG Analysis Platform Receives FDA Clearance
Technology | ECG Monitoring Services| July 13, 2017
Cardiologs Technologies SAS announced that it has received U.S. Food and Drug Administration (FDA) clearance of its...
Overlay Init